date,title,source
Nov-05-18,Arcturus Therapeutics Hosts Ribbon Cutting Ceremony for its Research and Development Facility,GlobeNewswire
Nov-07-18,Arcturus Therapeutics Provides Corporate Update and Reports Third Quarter 2018 Financial Results,GlobeNewswire
Dec-03-18,Arcturus Therapeutics to Host a Key Opinion Leader Call on Ornithine Transcarbamylase (OTC) Deficiency on December 11,GlobeNewswire
Dec-18-18,Activists Having Busier-Than-Ever 2018 as Icahn Returns to Fray,Bloomberg
Dec-21-18,Do Insiders Own Lots Of Shares In Arcturus Therapeutics Ltd. (NASDAQ:ARCT)?,Simply Wall St.
Dec-31-18,Penny Stocks to Buy Using Technical Analysis for January 2019,Investopedia
Jan-02-19,Arcturus Therapeutics to Develop ARCT-810 for Treatment of Ornithine Transcarbamylase (OTC) Deficiency,GlobeNewswire
Jan-03-19,Arcturus Therapeutics Appoints Andrew Sassine as Chief Financial Officer,GlobeNewswire
Jan-22-19,Penny Stocks to Buy Using Technical Analysis for January 2019,Investopedia
Feb-11-19,Arcturus Therapeutics to Present at Upcoming Investor Conferences,GlobeNewswire
Feb-11-19,"Arcturus Therapeutics Reassumes Full Worldwide Rights to ARCT-810, a Clinical Development Candidate for Ornithine Transcarbamylase (OTC) Deficiency",GlobeNewswire
Mar-18-19,Arcturus Therapeutics Provides Corporate Update and Reports Fourth Quarter and Year End 2018 Financial Results,GlobeNewswire
Mar-28-19,Four Healthcare Stocks Getting a Boost on Thursday,ACCESSWIRE
May-13-19,"Arcturus Therapeutics (ARCT) Reports Q1 Loss, Tops Revenue Estimates",Zacks
May-13-19,Arcturus Therapeutics Announces First Quarter Financial Results and Provides a Corporate Update,GlobeNewswire
Jun-13-19,Arcturus Therapeutics Announces Redomiciliation to the United States as a Delaware Corporation,GlobeNewswire
Jun-19-19,Ultragenyx and Arcturus Therapeutics Expand Existing Research Collaboration and License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases,GlobeNewswire
